ICP
ELV icon

Ilex Capital Partners’s Elevance Health ELV Stock Holding History

Ilex Capital Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,335
Closed -$431K – 101
2025
Q3 		$431K Sell
1,335
-2,072
-61% -$644K 0.01% 109
2025
Q2 		$1.33M Sell
3,407
-4,200
-55% -$1.69M 0.04% 88
2025
Q1 		$3.31M Buy
+7,607
New +$3.05M 0.14% 45

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Ilex Capital Partners's ELV Position: Q4 2025 in Review

Ilex Capital Partners sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 1,335 shares — an estimated $431K sold.

Ilex Capital Partners first reported a position in ELV in Q1 2025 and held it in 3 quarters. The position peaked at $3.31M in Q1 2025. 1,553 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Ilex Capital Partners reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Ilex Capital Partners sold 1,335 Elevance Health shares in Q4 2025, an estimated $431K.
  • Ilex Capital Partners first reported a position in Elevance Health in Q1 2025 and held it in 3 quarters.
  • Ilex Capital Partners's Elevance Health position peaked at $3.31M in Q1 2025.
  • 1,553 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Ilex Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.